Walgreens Boots Alliance Executive Compensation (FY24)
WBA · Executive and director compensation, fiscal 2022 to 2024
Chief executive, fiscal 2024 ◇ Timothy Wentworth | Median of the other named officers $6,652,962 5 officers, excluding the chief executive | Latest say-on-pay support = January 30, 2025 |
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
The Walgreens Boots Alliance brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $900.
Data as of November 5, 2026Latest filing (8-K): February 5, 2025
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
153 figures on this page: 143 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
What changed from fiscal 2023 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Say-on-pay support: 86.4% → 90.3% (3.9 points higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Walgreens Boots Alliance's chief executive and what were they paid?
Timothy Wentworth, Chief Executive Officer, received $13,282,800 in total compensation for fiscal 2024.
What was Walgreens Boots Alliance's say-on-pay result?
The say-on-pay proposal drew 90.3% of votes cast including abstentions in favor at the meeting held January 30, 2025 for fiscal 2024.
Which companies are in Walgreens Boots Alliance's peer group?
Companies named in the disclosed peer group include Cigna, Coca-Cola, Costco, CVS Health and Humana, among others.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Rosalind Brewer Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Stefano Pessina Executive Chairman | — | — | ◇ | — | — | — | ◇ | ◇ |
Ornella Barra Chief Operating Officer, International | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
James Kehoe Executive Vice President and Global Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
John Standley Former Executive Vice President, Walgreens Boots Alliance, Inc. and President, Walgreens Departed during or after this year | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Stefano Pessina Executive Chairman | — | — | ◇ | — | — | — | ◇ | ◇ |
Ornella Barra Chief Operating | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Manmohan Mahajan Global Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Timothy Wentworth Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Stefano Pessina Executive Chairman | — | — | ◇ | — | — | — | ◇ | ◇ |
Ornella Barra Chief Operating Officer, International | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Mary Langowski Executive Vice President and President, U.S. Healthcare | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Manmohan Mahajan Global Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Ginger Graham Former Interim Chief Executive Officer Departed during or after this year Served on an interim basis | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Manmohan Mahajan | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Ginger Graham | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Ornella Barra | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2024
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Nancy M. Schlichting | ◇ | ◇ | — | — | — | — | ◇ |
Janice M. Babiak | ◇ | ◇ | — | — | — | ◇ | ◇ |
Ginger L. Graham Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
John A. Lederer | ◇ | ◇ | — | — | — | — | ◇ |
Inderpal S. Bhandari | ◇ | ◇ | — | — | — | — | ◇ |
Valerie B. Jarrett | ◇ | ◇ | — | — | — | — | ◇ |
Bryan C. Hanson | ◇ | ◇ | — | — | — | — | ◇ |
Dominic P. Murphy | ◇ | ◇ | — | — | — | — | ◇ |
Thomas E. Polen | ◇ | ◇ | — | — | — | — | ◇ |
Robert L. Huffines | ◇ | — | — | — | — | — | ◇ |
Manmohan Mahajan | — | — | ◇ | — | — | — | — |
Stefano Pessina, Timothy C. Wentworth, Ornella Barra and Mary Langowski served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as Stock.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
- Cigna CI
- Coca-Cola KO
- Costco COST
- CVS Health CVS
- Humana HUM
- Johnson & Johnson JNJ
- Kroger KR
- McDonald's MCD
- McKesson MCK
- Medtronic MDT
- Mondelez MDLZ
- PepsiCo PEP
- Pfizer PFE
- Procter & Gamble PG
- Target TGT
- Wal- Mart symbol not shown
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2024 | January 30, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | January 25, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | January 26, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | January 27, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | January 28, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | January 30, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | January 25, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | January 17, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | January 26, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | January 27, 2016 | = | ◇ | ◇ | ◇ |
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Timothy Wentworth (Chief Executive Officer), FY2024 total compensation $13,282,800 (base salary $1,290,385) [exec_comp, SEC accession 0001558370-24-016214, filed 2024-12-13]What this page does not include
Everything above is a fact Walgreens Boots Alliance disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Walgreens Boots Alliance sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
153 figures on this page: 143 cited to the filing that reported them, 10 calculated from figures it prints.
143 cited to the filing
10 calculated from the filing
Documents cited
- 0001193125-25-020848Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001558370-24-016214Director Compensation · Executive Compensation Tables and Supporting Information
- 0001193125-24-021052Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001308179-23-001069Executive Compensation Tables and Supporting Information
- 0001193125-23-020487Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001308179-22-0003902022 Summary Compensation Table
- 0001193125-22-021722Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001359948-21-000018Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-20-023440Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-19-021048Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-18-013986Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-17-022888Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-16-445174Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Walgreens Boots Alliance executive compensation, FY2022–FY2024.” https://intel.velarion.ai/comp/WBA (accessed 2026).
Short form: data: Velarion
The Walgreens Boots Alliance brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $900.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Walgreens Boots Alliance and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Walgreens Boots Alliance discloses
The companies named in WBA's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}